Gilead Sciences's total assets for Q4 2023 were $62.13B, a decrease of -0.40% from the previous quarter. GILD total liabilities were $39.38B for the fiscal quarter, a -1.88% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.